Correction to: Impact of perinatal environmental health education intervention on exposure to endocrine disruptors during pregnancy—PREVED study: study protocol for a randomized controlled trial

• Houria E. L. Ouazzani,
• Steeve Rouillon,
• Nicolas Venisse,
• Lynda Sifer-Rivière,
• Antoine Dupuis,
• Guillaume Cambien,
• Sarah Ayraud-Thevenot,
• Anne-Sophie Gourgues,
• Pascale Pierre-Eugène,
• Fabrice Pierre,
• Sylvie Rabouan,
• DisProSE Group,
• Virginie Migeot,
• Marion Albouy-Llaty

Affiliations

Houria E. L. Ouazzani

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Steeve Rouillon

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Nicolas Venisse

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Lynda Sifer-Rivière

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Antoine Dupuis

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Guillaume Cambien

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Sarah Ayraud-Thevenot

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Anne-Sophie Gourgues

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Pascale Pierre-Eugène

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Fabrice Pierre

BioSPharm Pole, University Hospital of Poitiers

Sylvie Rabouan

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

DisProSE Group

Virginie Migeot

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers

Marion Albouy-Llaty

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers